TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16929421

Group type: EXPERIMENTAL
Intervention: 50 microg oral misoprostol every 4 h (treatment group 1)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 100 microg oral misoprostol every 4 h (treatment group 2)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (vitamin B6 50 mg, control)
Number of subjects: 100
Study: 12922104

Group type: EXPERIMENTAL
Intervention: Priming dose of Avaxim pediatric hepatitis A vaccine given at 6 months of age (Group 2)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Priming dose of Avaxim pediatric hepatitis A vaccine given 2 weeks after routine vaccinations (Group 1)
Number of subjects: 108
Study: 10831287

Group type: EXPERIMENTAL
Intervention: Thrombopoietin (TPO)
Number of subjects: 0
Study: 8775591

Group type: EXPERIMENTAL
Intervention: 12-month therapeutic community (TC) program
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: 6-month relapse prevention (RP) program
Number of subjects: 495

Group type: COMPARATOR
Intervention: 6-month therapeutic community (TC) program
Number of subjects: 495

Group type: COMPARATOR
Intervention: 3-month relapse prevention (RP) program
Number of subjects: 495
Study: 1294401

Group type: EXPERIMENTAL
Intervention: hCG (10,000 IU i.m. on first diagnosis of pregnancy, 5000 IU twice weekly to week 12, then once weekly to week 16)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo (identical ampoulage)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: hCG (for patients with no defined cause for habitual abortion)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo (for patients with no defined cause for habitual abortion)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: hCG and Placebo
Number of subjects: 75
Study: 6536512

Group type: EXPERIMENTAL
Intervention: Alphaxalone
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Alphadolone
Number of subjects: 7
Study: 31335349

Group type: EXPERIMENTAL
Intervention: Blood-based protein assay
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no blood-based protein assay)
Number of subjects: 0
Study: 29795527

Group type: EXPERIMENTAL
Intervention: 5 mg tadalafil once a day
Number of subjects: 63

Group type: COMPARATOR
Intervention: 20 mg tadalafil on-demand (four times a month)
Number of subjects: 63
Study: 27255448

Group type: EXPERIMENTAL
Intervention: Neurostimulator (group N, n = 60)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Ultrasound (group U, n = 60)
Number of subjects: 120
Study: 23322261

Group type: EXPERIMENTAL
Intervention: Alexander Technique (AT) with 12 weekly home-based lessons in addition to usual care
Number of subjects: 120

Group type: COMPARATOR
Intervention: Usual care from Guide Dogs NSW/ACT
Number of subjects: 120
Study: 23071635

Group type: EXPERIMENTAL
Intervention: Testosterone (50 mg transdermal administration)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study: 20191485

Group type: COMPARATOR
Intervention: Anti-tumor necrosis factor therapy (exact dosage and duration not specified)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Dichotomous scoring method for posterior element inflammation
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: MRI evaluation of posterior elements
Number of subjects: 32
Study: 18569128

Group type: EXPERIMENTAL
Intervention: Rehabilitation & Sports (R&S) + Active after Rehabilitation (AaR)
Number of subjects: 887

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 887
Study: 16046345

Group type: EXPERIMENTAL
Intervention: Multicomponent exercise training for nine weeks followed by six weeks of detraining
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Multicomponent exercise training followed by six weeks of detraining
Number of subjects: 21
Study: 12071689

Group type: EXPERIMENTAL
Intervention: Repeated presentations of the same food
Number of subjects: 35

Group type: COMPARATOR
Intervention: Variety of isocaloric food
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: All participants
Number of subjects: 35
Study: 10618938

Group type: EXPERIMENTAL
Intervention: Eltanolone
Number of subjects: 18

Group type: COMPARATOR
Intervention: Alfentanil
Number of subjects: 18
Study: 7567422

Group type: EXPERIMENTAL
Intervention: Flotation REST (floating in a commercially produced tank)
Number of subjects: 7

Group type: COMPARATOR
Intervention: In-bed REST (lying alone on a bed in an isolation box)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Flotation REST
Number of subjects: 7

Group type: COMPARATOR
Intervention: In-bed REST
Number of subjects: 7
Study: 1827394

Group type: EXPERIMENTAL
Intervention: Intensive foot care intervention
Number of subjects: 0
Study: 7097422

Group type: EXPERIMENTAL
Intervention: Protein supplement isolated from mature human milk, increasing protein content by 0.8 gm/dl
Number of subjects: 18

Group type: COMPARATOR
Intervention: Unsupplemented group
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Protein intake of more than 3 gm/kg/day
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both groups (supplemented and unsupplemented)
Number of subjects: 18
Study: 31588477

Group type: EXPERIMENTAL
Intervention: ShotBlocker
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Cold spray
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control
Number of subjects: 120
Study: 29578832

Group type: EXPERIMENTAL
Intervention: Daily motivational text messages, additional texted tips in response to keywords, and weekly study questions
Number of subjects: 150

Group type: COMPARATOR
Intervention: Weekly study questions only
Number of subjects: 150
Study: 26855121

Group type: EXPERIMENTAL
Intervention: Small Change Approach (SCA)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 320
Study: 24845190

Group type: EXPERIMENTAL
Intervention: Real-life observation of stressor
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Intimate observer-target dyads
Number of subjects: 362

Group type: COMPARATOR
Intervention: Virtual observation modality
Number of subjects: 362

Group type: COMPARATOR
Intervention: Stranger observation
Number of subjects: 362
Study: 23018233

Group type: EXPERIMENTAL
Intervention: Clopidogrel 50 mg once daily
Number of subjects: 1110

Group type: EXPERIMENTAL
Intervention: Clopidogrel 75 mg once daily
Number of subjects: 1110
Study: 20844075

Group type: EXPERIMENTAL
Intervention: 100% Concord grape juice (7 mL · kg⁻¹ · d⁻¹)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Matched placebo beverage
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 100% Concord grape juice
Number of subjects: 64
Study: 17270515

Group type: EXPERIMENTAL
Intervention: New orthosis
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: New orthosis after 3 weeks of familiarization
Number of subjects: 27
Study: 16094738

Group type: EXPERIMENTAL
Intervention: Sequential radical radiotherapy and cisplatin-based chemotherapy
Number of subjects: 288

Group type: COMPARATOR
Intervention: Radical radiotherapy alone
Number of subjects: 288
Study: 12084743

Group type: EXPERIMENTAL
Intervention: Trabeculectomy with intraoperative antimetabolites (5‐fluorouracil 25 mg/ml, mitomycin C 0.2 mg/ml and 0.4 mg/ml)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Viscocanalostomy with intraoperative intracanalicular Healonid GV injection
Number of subjects: 48

Group type: COMPARATOR
Intervention: Viscocanalostomy with balanced saline solution
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Trabeculectomy
Number of subjects: 48
Study: 9448865

Group type: EXPERIMENTAL
Intervention: Preadmission structured education
Number of subjects: 50

Group type: COMPARATOR
Intervention: Postadmission unstructured education
Number of subjects: 50
Study: 7887720

Group type: EXPERIMENTAL
Intervention: Preoperative autologous donation (group 1)
Number of subjects: 348

Group type: COMPARATOR
Intervention: Control group (group 2)
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: Patients with three units of predonated autologous blood (group 1)
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: Other blood conservation measures (both groups)
Number of subjects: 348
Study: 2296627

Group type: EXPERIMENTAL
Intervention: Moclobemide (200 mg t.i.d.)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Clomipramine (25 mg b.i.d.)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Alcohol (0.6 g/l blood alcohol concentration)
Number of subjects: 24
Study: 340155

Group type: EXPERIMENTAL
Intervention: Isoniazid (INH)
Number of subjects: 7036

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7036
Study: 31784904

Group type: EXPERIMENTAL
Intervention: Adaptive-Servo Ventilation (ASV)
Number of subjects: 749
Study: 31090488

Group type: EXPERIMENTAL
Intervention: Ketamine (0.8 mg/kg mixed in juice, administered 30 minutes before procedure)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo (only juice)
Number of subjects: 52
Study: 28237604

Group type: EXPERIMENTAL
Intervention: High velocity resistance training (HVRT) at 240°/s
Number of subjects: 26

Group type: COMPARATOR
Intervention: Low velocity resistance training (LVRT) at 75°/s
Number of subjects: 26
Study: 26347966

Group type: EXPERIMENTAL
Intervention: Intraperitoneal, dual-component onlay mesh
Number of subjects: 70

Group type: COMPARATOR
Intervention: Traditional stoma (Control)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Intervention
Number of subjects: 70
Study: 23631560

Group type: EXPERIMENTAL
Intervention: Phenol matricectomy (PM)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Nail-splinting using a flexible tube (FT)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 120
Study: 21320258

Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124
Study: 19165681

Group type: EXPERIMENTAL
Intervention: Early feeding
Number of subjects: 200

Group type: COMPARATOR
Intervention: Routine feeding
Number of subjects: 200
Study: 17102644

Group type: EXPERIMENTAL
Intervention: Meningococcal C conjugate (MCC) vaccines administered at the same time as DT/Td boosters
Number of subjects: 1754

Group type: EXPERIMENTAL
Intervention: Meningococcal C conjugate (MCC) vaccines administered a month before or after DT/Td boosters
Number of subjects: 1754

Group type: EXPERIMENTAL
Intervention: Use of analgesics/antipyretic medication
Number of subjects: 1754

Group type: EXPERIMENTAL
Intervention: All subjects post-vaccination
Number of subjects: 1754

Group type: EXPERIMENTAL
Intervention: MCC vaccines under the above schedules
Number of subjects: 1754
Study: 15603004

Group type: EXPERIMENTAL
Intervention: Customized Employment Supports (CES) model
Number of subjects: 121

Group type: COMPARATOR
Intervention: Standard vocational counseling
Number of subjects: 121
Study: 11269570

Group type: EXPERIMENTAL
Intervention: Tolterodine L-tartrate 2 mg administered with a standardized medium-fat breakfast
Number of subjects: 23

Group type: COMPARATOR
Intervention: Tolterodine L-tartrate 2 mg administered on an empty stomach
Number of subjects: 23
Study: 10998085

Group type: EXPERIMENTAL
Intervention: Nitroglycerine (1 mg h‐1)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nitroglycerine (2 mg h‐1)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 12
Study: 8792277

Group type: EXPERIMENTAL
Intervention: 400 ml of milk containing B. longum B6 grown with lactose
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 400 ml of milk containing B. longum B6 grown with lactose plus glucose
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 400 ml of milk containing B. longum ATCC 15708 grown with lactose
Number of subjects: 15

Group type: COMPARATOR
Intervention: 400 ml of lowfat milk (control)
Number of subjects: 15
Study: 1379256

Group type: EXPERIMENTAL
Intervention: GHRH-(1-29) high dose (1 mg) sc injections twice daily for 14 days
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: GHRH-(1-29) low dose (0.5 mg) sc injections twice daily for 14 days
Number of subjects: 10

Group type: COMPARATOR
Intervention: Baseline measurements
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: GHRH treatment
Number of subjects: 10
Study: 6522416

Group type: EXPERIMENTAL
Intervention: Flurazepam 15 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Flurazepam 30 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30711987

Group type: EXPERIMENTAL
Intervention: Comprehensive pharmaceutical interventions
Number of subjects: 50
Study: 29972884

Group type: EXPERIMENTAL
Intervention: 75 mg acetylsalicylic acid
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study: 26782102

Group type: EXPERIMENTAL
Intervention: Intravenous glyceryltrinitrate (GTN) at a maximum tolerable dosage (6.2 ± 1.5 mg/h)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Inhalation of iloprost (10 μg/mL)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group: intravenous or inhaled sodium chloride (NaCl) 0.9%
Number of subjects: 21
Study: 25237048

Group type: EXPERIMENTAL
Intervention: NEXT Step home exercise program
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Supervised exercise program
Number of subjects: 180

Group type: COMPARATOR
Intervention: Attention-control group (light resistance training)
Number of subjects: 180
Study: 22171925

Group type: EXPERIMENTAL
Intervention: Celivarone 50 mg
Number of subjects: 673

Group type: EXPERIMENTAL
Intervention: Celivarone 100 mg
Number of subjects: 673

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 673

Group type: COMPARATOR
Intervention: Amiodarone
Number of subjects: 673

Group type: EXPERIMENTAL
Intervention: Celivarone 300 mg
Number of subjects: 673

Group type: EXPERIMENTAL
Intervention: Celivarone 600 mg
Number of subjects: 673
Study: 19406521

Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis indicated in all patients; overall adequacy of prophylaxis according to hospital protocol was 89.1%
Number of subjects: 221
Study: 17664057

Group type: EXPERIMENTAL
Intervention: Anti-inflammatory blend rich in polyunsaturated fatty acids (alpha-linolenic acid, 240 mg/d; eicosapentaenoic acid, 120 mg/d; stearidonic acid, 49 mg/d; gamma-linolenic acid, 73 mg/d)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Inflammatory fat blend (arachidonic acid, 40 mg/d)
Number of subjects: 30
Study: 15841721

Group type: EXPERIMENTAL
Intervention: Helicobacter DNA detection in gallbladder samples
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Helicobacter DNA detection in liver samples
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Presence of H. pylori specific cytotoxins CagA and VacA
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Correlation between Helicobacter DNA and IgG antibody responses
Number of subjects: 22
Study: 12200947

Group type: EXPERIMENTAL
Intervention: Target-controlled propofol alone
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Target-controlled propofol and target-controlled remifentanil (3 ng mL‐1)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Midazolam (0.03 mg kg‐1), target-controlled remifentanil (3 ng mL‐1) and target-controlled propofol
Number of subjects: 66
Study: 9578242

Group type: EXPERIMENTAL
Intervention: Endurance training (5 weeks) in trained females (17 subjects)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Endurance training (5 weeks) in trained males (20 subjects)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group females (15 subjects)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group males (10 subjects)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Endurance training (5 weeks) in trained females and males
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group (combined)
Number of subjects: 88
Study: 7635409

Group type: EXPERIMENTAL
Intervention: Interferon alfa (IFN‐alpha) treatment for 4 months
Number of subjects: 223

Group type: COMPARATOR
Intervention: Nontreated patients
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Interferon alfa (IFN‐alpha) treatment
Number of subjects: 223
Study: 2792176

Group type: EXPERIMENTAL
Intervention: Lactitol (20-40 g per day for one month)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control period without lactitol
Number of subjects: 12
Study: 30878999

Group type: EXPERIMENTAL
Intervention: Extended-release calcifediol (ERC)
Number of subjects: 429

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 429
Study: 28849265

Group type: EXPERIMENTAL
Intervention: Intraoperative chemotherapy (portal vein chemotherapy, intraluminal chemotherapy, and intraperitoneal chemotherapy) plus surgery
Number of subjects: 696

Group type: COMPARATOR
Intervention: Control (surgery alone)
Number of subjects: 696

Group type: EXPERIMENTAL
Intervention: Intraoperative chemotherapy
Number of subjects: 696
Study: 26090383

Group type: EXPERIMENTAL
Intervention: RBTM (rabeprozole 20 mg bid., bismuth subcitrate 120 mg qid, tetracycline 500 mg qid, and metronidazole 250 mg qid)
Number of subjects: 124

Group type: COMPARATOR
Intervention: RATM (rabeprozole 20 mg bid., amoxicillin 1 g bid., tetracycline 500 mg qid, and metronidazole 250 mg qid)
Number of subjects: 124

Group type: COMPARATOR
Intervention: RATM
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: RBTM
Number of subjects: 124
Study: 23497763

Group type: EXPERIMENTAL
Intervention: Mirabegron OCAS 50 mg after a high-fat breakfast
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Mirabegron OCAS 50 mg after a low-fat breakfast
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Mirabegron OCAS 100 mg after a high-fat breakfast
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Mirabegron OCAS 100 mg after a low-fat breakfast
Number of subjects: 76
Study: 21258027

Group type: EXPERIMENTAL
Intervention: Pharmacologic therapy for smoking cessation
Number of subjects: 816

Group type: EXPERIMENTAL
Intervention: Pharmacologic therapy for smoking cessation (short-term follow-up ≤ 12 weeks)
Number of subjects: 816

Group type: EXPERIMENTAL
Intervention: Pharmacologic therapy for smoking cessation (mid-term follow-up 26 weeks)
Number of subjects: 816
Study: 19237436

Group type: EXPERIMENTAL
Intervention: Qigong exercise intervention (1 hour per week for 8 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Non-exercise-based social and leisure activities (control)
Number of subjects: 20
Study: 16773754

Group type: EXPERIMENTAL
Intervention: Stapled hemorrhoidectomy
Number of subjects: 0
Study: 15590048

Group type: EXPERIMENTAL
Intervention: Last Observation Carried Forward (LOCF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ignorable Maximum Likelihood (IML)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple Imputation (MI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Piecewise splines and rescue (treatment adjustment)
Number of subjects: 0
Study: 11716885

Group type: EXPERIMENTAL
Intervention: Stroke unit care
Number of subjects: 304

Group type: COMPARATOR
Intervention: General ward care
Number of subjects: 304
Study: 9249123

Group type: EXPERIMENTAL
Intervention: Propofol infusion
Number of subjects: 15
Study: 8424497

Group type: EXPERIMENTAL
Intervention: 50 g of glucose mixed with 100 U of human insulin (HI/100)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 50 g of glucose mixed with 100 U of bovine insulin (BI/100)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 50 g of glucose mixed with 50 U of human insulin (HI/50)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 50 g of glucose mixed with 50 U of bovine insulin (BI/50)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: GIK (all groups)
Number of subjects: 50
Study: 3118005

Group type: EXPERIMENTAL
Intervention: sulbactam/ampicillin/gentamicin
Number of subjects: 29

Group type: COMPARATOR
Intervention: clindamycin/gentamicin
Number of subjects: 29
Study: 29650034

Group type: EXPERIMENTAL
Intervention: Real-time visual biofeedback about weight-bearing during gait in addition to care as usual
Number of subjects: 188

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 188
Study: 28808030

Group type: EXPERIMENTAL
Intervention: Nasal delivery of oxytocin paired with peer-derived altruistic norms
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Nasal delivery of oxytocin
Number of subjects: 183

Group type: COMPARATOR
Intervention: Participants with higher levels of xenophobia
Number of subjects: 183
Study: 25365778

Group type: EXPERIMENTAL
Intervention: Mindful awareness and acceptance treatment (M)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy for pain (CBT-P)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Arthritis education (E)
Number of subjects: 143
Study: 24024323

Group type: EXPERIMENTAL
Intervention: Erbanxiao solution
Number of subjects: 60

Group type: COMPARATOR
Intervention: Compound Kushen injection
Number of subjects: 60
Study: 21401941

Group type: EXPERIMENTAL
Intervention: Continence nurse practitioner (CNP) intervention
Number of subjects: 3746

Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 3746
Study: 18416260

Group type: COMPARATOR
Intervention: Monofocal IOL (Tecnis Z9000)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Symmetric diffractive multifocal IOL (Tecnis ZM900)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Zonal refractive multifocal IOL (ReZoom)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Asymmetric diffractive multifocal IOL (TwinSet)
Number of subjects: 114
Study: 16850289

Group type: EXPERIMENTAL
Intervention: Randomized Controlled Trials (RCTs)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Controlled Clinical Trials (CCTs)
Number of subjects: 112

Group type: COMPARATOR
Intervention: International Surgical Journals
Number of subjects: 112
Study: 12554382

Group type: EXPERIMENTAL
Intervention: Treatment in a rehabilitation centre in Tenerife for four weeks (Group 1, n=30)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Treatment in two similar centres in Norway for four weeks (Group 2, n=29)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Ordinary health care programme (Control Group 3, n=29)
Number of subjects: 88
Study: 11097585

Group type: EXPERIMENTAL
Intervention: Predicted flap thickness of 160 micrometer
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Predicted flap thickness of 180 micrometer
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Predicted flap thickness of 200 micrometer
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Predicted tissue ablation
Number of subjects: 60
Study: 8865507

Group type: EXPERIMENTAL
Intervention: Self-adjusting pressure mode
Number of subjects: 12

Group type: COMPARATOR
Intervention: Standard NCPAP mode
Number of subjects: 12